{"id":470665,"date":"2021-04-05T08:03:29","date_gmt":"2021-04-05T12:03:29","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470665"},"modified":"2021-04-05T08:03:29","modified_gmt":"2021-04-05T12:03:29","slug":"pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/","title":{"rendered":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., April  05, 2021  (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced its participation in the 20<sup>th<\/sup> Annual Needham Healthcare Conference to be held virtually from April 12 \u201315, 2021.<\/p>\n<p align=\"justify\">Bernard Coulie, M.D., Ph.D., Pliant\u2019s President and Chief Executive Officer, will participate in a fireside chat with Needham and Company\u2019s senior biotech analyst, Joseph Stringer, on Tuesday, April 13, 2021 at 12:45 p.m. EDT \/ 9:45 a.m. PDT and, along with members of Pliant\u2019s senior management team, will conduct one-on-one meetings with members of the investment community.<\/p>\n<p align=\"justify\">The live and archived event can be accessed by visiting the &#8220;News &amp; Events&#8221; section of the &#8220;Investors &amp; Media&#8221; page of the Pliant Therapeutics&#8217; website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uUN2Dwa_wOxEeLSrAbW_P_o8FWbqyvnEvgJIM8JFJWsgg2D8z2RCX1EcGbux5dJQd1uyXLDN9SZU9e_sBJME7w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.pliantrx.com<\/a>. The event will be available for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About\u00a0Pliant Therapeutics, Inc.<\/strong><br \/>\n        <br \/>Pliant Therapeutics\u00a0is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Pliant&#8217;s lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of a<sub>v<\/sub>\u00df<sub>6<\/sub>\u00a0and a<sub>v<\/sub>\u00df<sub>1<\/sub>\u00a0integrins that is in development for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. PLN-74809 has received Orphan Drug Designation from the\u00a0U.S. Food and Drug Administration\u00a0for both IPF and PSC. Pliant is currently recruiting Phase 2a trials of PLN-74809 for the treatment of IPF and PSC. Pliant&#8217;s second product candidate, PLN-1474, is a small-molecule selective inhibitor of a<sub>v<\/sub>\u00df<sub>1<\/sub>\u00a0for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, which Pliant has partnered with Novartis. In addition to clinical stage programs, Pliant currently has two preclinical programs targeting oncology and muscular dystrophies. For additional information about\u00a0Pliant Therapeutics, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uUN2Dwa_wOxEeLSrAbW_P7XZS_nBJk5MDiKmEf6y3ycVqCB8lqOulM4gm7zVa2ExL2P_81VMp9-FIw6uWGQ8dHKCbINrVRpq2WHRZpDihknBAGNa_3fQEcYPtywnCXdEk2kgMzKXN-EVJDRknl3xd-ljZlv5abvpdtYz4F6ZchLSvoYXn-cVPhfXPth6LTJFpU-R8x_8iWeO226SadkdiBBEuhdak1e_yDddXtU_IkoG4Dv6inPNtz7GavTBYLuicTNqtQLBZLQ4M7oV2Ce-1DkrQkvov8rjSA-5Ni28fchNdH3Ya-ipGLgKs5-7Ry2FHxsfmuqfgaTap4gp49ipkDuf9rVQRA4LvDKxEyvRiqsyK7YDyprjI56-hYOy3o1wpXTStUSFuPzknYuKTj65Zg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.pliantrx.com<\/u><\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AihZvFQxLGnSekJPESKnc_8qbNhakDHl6Gw5Fa_E_9PP_zb-ukJeFw6VTFpE8-6JKZkDSL_rjjLTXb6jxuO1NJfS4wthJ0crhoaNhMMPsGuqMUy9B8EQ7l9osnbM91HNoVN4eVTH6C-k0b0xdz7TA-FBPipbxk_zRgEfQdHpX-WeSBOej-Vu6i6lGOutBJPYQmKyclfBtAFnqtiqg4WAHwRvcA65utTwHUfaH91N92SGGVZnzE0J7tY5AhSr0IVgGbBI6wJOMET7OUFy7nsFDpCbakbZoZ8vv4FpOUqLwaNdMPvbBizKKGahSyo6Ux84EzxTaue5nnI3oZBKMbRo5851KiiEVo5fMUXjEZomFCA=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Twitter<\/u><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-nx9UXR4W3xlud_GueKJBzsf2LIP733JlYOe3dq98KiMcBB-onHvQB9B9Vi-eew0tOzQ0vh27QlCR5gzUxtbwlI8FIeAJ4CVvFujkfjtU-bI1IC12EVkGXKF3kyhZqsV6eebds106480nb2qCvYI3J0ayJtBRY9rGH6YH-0Z-tWg-8AMz8njLtzBplGNZDui8GjnzWmnG8nHtYybu1ZCnqODwBk-ZQJJnd8ODF5agLlSY9U1vY8373s1WXz3gAwrwxQUqzeRECT7aVJwIAgvj9Ydln01wAPEdlzVdzM8ay400DTmyNfNFsNPCKTXFLOEKuBMPYS8Rn1gB-Vd_Tpte4_6tNYimsV9PXBjdn82KqZMFk0KOUWWk7htghV1_kNpFUQ9eK3Dy76_f-q4YlKpyaTvFXUlGKOd7gAxeQXbTWU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>LinkedIn<\/u><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VeJjbfLDFdD-s3A_KX4wmCfeRFflhV6URpOV8nr38qndTvp9Xv0rmGOZfnPHYtcypJUaNsfmIXDzeIUyfWL-KtqbSESi_UY_yaBoUtMVoEOjo-kYZG8X43Sm32l_pIsQNfyX0V9do1UQjerDWSNpN80kK8lHR_pt29rEMYRq52ULCksexTOHm5_N02v4S461i2nWpSDAiDkFz2iNcRozGQEP5MMOzeth-a_U9m91OSzL9qBT9FMFY5OhVq4h60Qg0Attea4tDPVusA1PLXNyrLXMjG1V5nCHUdbOChhLIm1xQieJq6KvQqtPI-n-SOEOnTqRJ4ofM6ax1K1Ti2sh4viBed3i8UCovYdMq8Wve-E=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>Facebook<\/u><\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l7f-LYMZ400pkAc31dm-2pBsx7bsIiu7Tb8tGSfSXAtm5kggKobtPXTdGqIiorHgdArdZJMaNec7xdFEO4kqemC7YnUQG5yEvWAGNP9uNDLkEbrfn-Ex9NvER3J4I7pwDyMvrhmyVnxRW9w67CkOSZZNbYLds5VpeJk1PQsNz_msTb-C7jW4wobRG_UCQX03CWLuLhZLKlIWQA0Ew21J6B11Kz7h1-VtX326YZrUx3NNfiUH6V5MxKg2hm4pX9WXwcsK_WJZZCDSgZPD8ModjA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Investor and Media Contact:<\/strong><br \/>\n        <br \/>Christopher Keenan<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Pliant Therapeutics, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vDJYRnD0G_Vcl9imrm_S_evviSbU2mPxEXJwuCTtQZBthHy6Rdt6DFUZVkFxF5X-pXo377kqr1zYufPH3qEqH8Iv8DDQMjynyQejfQgSy-a5s2ib6WOrwD6iHmz336k35yRp_TjB7IKJz3hkU55XQQV5j1xLj-DUBuFLpeIaYH23s1mV8x7XyCZNjjDh64EMctFwXnTt_XtmeOOV_3Wct4CgqjVpMwiRnDqctJ1kW8zijVw79hbERLepFeIiVG1p6hUkLEPr7_odHFFMuGh-EDqXb2kIhW15qAc0kVn_oqELshZU-07Mn0W7IDstGaJiW8FUL_ly-G7lif_znkf_ravZa5mc9lY_IcGPBMwYdZmx5IMgLY8Ml6Kmdfz42p5yZsV2vh1nBoVTGiTb9PwDawk9tn_ZDUHJ4s7pL0dxaCY=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>ir@pliantrx.com<\/u><\/a><\/p>\n<p align=\"justify\">\n        \n      <\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/c22e665a-6741-4928-b5b6-bff70a21f34b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced its participation in the 20th Annual Needham Healthcare Conference to be held virtually from April 12 \u201315, 2021. Bernard Coulie, M.D., Ph.D., Pliant\u2019s President and Chief Executive Officer, will participate in a fireside chat with Needham and Company\u2019s senior biotech analyst, Joseph Stringer, on Tuesday, April 13, 2021 at 12:45 p.m. EDT \/ 9:45 a.m. PDT and, along with members of Pliant\u2019s senior management team, will conduct one-on-one meetings with members of the investment community. The live and archived event can be accessed by visiting the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470665","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced its participation in the 20th Annual Needham Healthcare Conference to be held virtually from April 12 \u201315, 2021. Bernard Coulie, M.D., Ph.D., Pliant\u2019s President and Chief Executive Officer, will participate in a fireside chat with Needham and Company\u2019s senior biotech analyst, Joseph Stringer, on Tuesday, April 13, 2021 at 12:45 p.m. EDT \/ 9:45 a.m. PDT and, along with members of Pliant\u2019s senior management team, will conduct one-on-one meetings with members of the investment community. The live and archived event can be accessed by visiting the &hellip; Continue reading &quot;Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T12:03:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference\",\"datePublished\":\"2021-04-05T12:03:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/\"},\"wordCount\":331,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/\",\"name\":\"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\",\"datePublished\":\"2021-04-05T12:03:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) &#8212; Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced its participation in the 20th Annual Needham Healthcare Conference to be held virtually from April 12 \u201315, 2021. Bernard Coulie, M.D., Ph.D., Pliant\u2019s President and Chief Executive Officer, will participate in a fireside chat with Needham and Company\u2019s senior biotech analyst, Joseph Stringer, on Tuesday, April 13, 2021 at 12:45 p.m. EDT \/ 9:45 a.m. PDT and, along with members of Pliant\u2019s senior management team, will conduct one-on-one meetings with members of the investment community. The live and archived event can be accessed by visiting the &hellip; Continue reading \"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T12:03:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference","datePublished":"2021-04-05T12:03:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/"},"wordCount":331,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/","name":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=","datePublished":"2021-04-05T12:03:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTEyNiM0MTA0ODcwIzIxODU0NzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pliant-therapeutics-to-participate-in-annual-needham-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pliant Therapeutics to Participate in Annual Needham Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470665"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470665\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}